Concepedia

Yingyi Yu

YY

Statistics

Publications

8

Citations

306

H-Index

8

Active since

2013

Affiliations

Qilu Hospital of Shandong University(Current)

Ministry of Education of the People's Republic of China

Shandong University

University of South Australia

Yingyi Yu is an author at Qilu Hospital of Shandong University specializing in hematology, medicine, and immunology.

ORCID

Publications per year

2013–2023

8

Publications

8

High-dose dexamethasone corrects impaired myeloid-derived suppressor cell function via Ets1 in immune thrombocytopenia

Yu Hou, Qi Feng, Miao Xu et al. · Blood · 2016 · 74 citations · Full text

, , +15

Platelet desialylation is a novel mechanism and a therapeutic target in thrombocytopenia during sepsis: an open-label, multicenter, randomized controlled trial

Mei-feng Li, Xiaoli Li, Kai-liang Fan et al. · Journal of Hematology & Oncology · 2017 · 74 citations · Full text

, , +17

CDKI-73: an orally bioavailable and highly efficacious CDK9 inhibitor against acute myeloid leukemia

Muhammed H. Rahaman, Yingyi Yu, Long‐Jin Zhong et al. · Investigational New Drugs · 2018 · 40 citations

, , +9

Interleukin 27 inhibits cytotoxic T-lymphocyte-mediated platelet destruction in primary immune thrombocytopenia

Hai Zhou, Jihua Qiu, Tong Wang et al. · Blood · 2014 · 37 citations · Full text

, , +14

Thalidomide corrects impaired mesenchymal stem cell function in inducing tolerogenic DCs in patients with immune thrombocytopenia

Ji Ma, Yunna Ning, Miao Xu et al. · Blood · 2013 · 28 citations · Full text

, , +16

1–5 of 8